Key result
KREN3 is an essential RNA editing endonuclease specifically required for cytochrome oxidase II mRNA editing and survival of Trypanosoma brucei bloodstream forms.
KREN3 (KREPB2) is an essential RNA editing endonuclease specifically required for COII mRNA editing and survival in Trypanosoma brucei.
KREPB2 editosomes specifically cleave COII substrates in vitro; leaves open in vivo roles and therapeutic targeting in trypanosomes.
Trypanosoma brucei has three distinct approximately 20S editosomes that catalyze RNA editing by the insertion and deletion of uridylates. Editosomes with the KREN1 or KREN2 RNase III type endonucleases specifically cleave deletion and insertion editing site substrates, respectively. We report here that editosomes with KREPB2, which also has an RNase III motif, specifically cleave cytochrome oxidase II (COII) pre-mRNA insertion editing site substrates in vitro. Conditional repression and mutation studies also show that KREPB2 is an editing endonuclease specifically required for COII mRNA editing in vivo. Furthermore, KREPB2 expression is essential for the growth and survival of bloodstream forms. Thus, editing in T. brucei requires at least three compositionally and functionally distinct approximately 20S editosomes, two of which distinguish between different insertion editing sites. This unexpected finding reveals an additional level of complexity in the RNA editing process and suggests a mechanism for how the selection of sites for editing in vivo is controlled.
No takes yet. Share an insight, caveat, or question.
Carnes et al. (2007) studied Trypanosoma brucei. KREN3 repression vs. Wild-type KREN3 was evaluated on COII mRNA editing and cell growth. KREN3 is an essential RNA editing endonuclease specifically required for cytochrome oxidase II mRNA editing and survival of Trypanosoma brucei bloodstream forms.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: